Repeat Two-Stage Exchange Arthroplasty for Recurrent Periprosthetic Joint Infection of the Hip: Sobering Results
The Journal of Arthroplasty · 2025-08 · 40 (8) · S310-S316
DOI: 10.1016/j.arth.2025.02.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2025-08. Verfasst von Aaron R Owen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Arthroplasty, Replacement, Hip, Reoperation, Hip Prosthesis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Mayo Clinic.
Abstract (Originalsprache)
BACKGROUND: A two-stage exchange arthroplasty is the standard management method of chronic periprosthetic joint infections (PJIs) of the hip in North America. However, a subset of patients become reinfected and may require a repeat two-stage exchange arthroplasty. The purpose of the present study was to assess revisions, reoperations, and risk factors for failure associated with repeat two-stage exchange arthroplasties for recurrent PJIs after total hip arthroplasty (THA). METHODS: We identified 52 repeat two-stage exchange THAs completed from 2000 to 2021 at a single, high-volume academic medical center. The mean age was 61 years, 39% were women, and the mean body mass index was 33. At the time of the repeat two-stage exchange, high-dose antibiotic spacers were used in 90% of patients (28 articulating, 19 nonarticulating), and 10% had a resection arthroplasty in the interim between stages. The mean time from repeat first stage to reimplantation was 33 weeks. At the final follow-up, 54% of patients were on chronic antibiotic therapy. The mean follow-up was 6 years. RESULTS: The 7-year survivorships free of re-revision for reinfection, any re-revision, and any reoperation were 85, 57, and 50%, respectively. The leading indications for re-revision were dislocation (45%) and PJI (35%). McPherson host grade C was a significant risk factor for re-revision for infection (HR [hazard ratio] 5, P = 0.04). Additionally, increased operative time at reimplantation was a risk for any reoperation (HR 1.06, P < 0.01) and reoperation for infection (HR 1.07, P < 0.01). At the final follow-up, 98% of patients had a revision THA in situ (one hip disarticulation). CONCLUSIONS: Repeat two-stage exchange arthroplasty of the hip had a 7-year survivorship free of re-revision for infection that was 85%, but only 57% were free of any re-revision (most due to revision for dislocation). McPherson C hosts had a 5-fold increased risk of reinfection. LEVEL OF EVIDENCE: Level IV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
Förderung
- Mayo Clinic
Zitieren
APA
Owen, A. R., Dilger, O. B., Bedard, N. A., Hannon, C. P., Mabry, T. M., Berry, D. J., & Abdel, M. P. (2025). Repeat Two-Stage Exchange Arthroplasty for Recurrent Periprosthetic Joint Infection of the Hip: Sobering Results. The Journal of Arthroplasty, 40(8), S310-S316. https://doi.org/10.1016/j.arth.2025.02.006
Vancouver
Owen AR, Dilger OB, Bedard NA, Hannon CP, Mabry TM, Berry DJ, et al. Repeat Two-Stage Exchange Arthroplasty for Recurrent Periprosthetic Joint Infection of the Hip: Sobering Results. The Journal of Arthroplasty. 2025;40(8):S310-S316. doi:10.1016/j.arth.2025.02.006
BibTeX
@article{Owen2025,
author = {Owen, Aaron R and Dilger, Oliver B and Bedard, Nicholas A and Hannon, Charles P and Mabry, Tad M and Berry, Daniel J and Abdel, Matthew P},
title = {Repeat Two-Stage Exchange Arthroplasty for Recurrent Periprosthetic Joint Infection of the Hip: Sobering Results},
journal = {The Journal of Arthroplasty},
year = {2025},
volume = {40},
number = {8},
pages = {S310--S316},
doi = {10.1016/j.arth.2025.02.006}
}
EUVIMED